Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...

Celecoxib improves disease-free and overall survival in ctDNA-positive stage III colon cancer patients when combined with standard chemotherapy. An analysis of patients with stage III colon patients ...

Region-specific biomarkers FGFR4, FLT1, and WNT5A are linked to tumor behavior and therapeutic response in CRC. Comprehensive genomic profiling (CGP) aids in precision medicine by identifying genetic ...

Dr. Yufei Liu discusses how updates to precision radiation therapy are reshaping colorectal cancer care. As Colorectal Cancer Awareness Month highlights the importance of early detection and ...

A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research Institute (IGTP) and from the ...

The FDA's fast track designation acknowledges the combination's promising early efficacy and safety profile in treating MSS mCRC. Early data from a phase 1b/2 study showed deep, durable responses with ...

The findings are particularly relevant for India, where colorectal cancer is emerging as a growing public health concern ...

A new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy drug, and atezolizumab, an immune checkpoint inhibitor, helped patients with metastatic colorectal cancer, ...

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center presented new research at the European Society for Medical Oncology (ESMO) Congress, covering advances in immunotherapy, targeted ...